Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
01 12 2022
Historique:
accepted: 12 06 2022
received: 31 12 2021
pubmed: 16 8 2022
medline: 6 12 2022
entrez: 15 8 2022
Statut: ppublish

Résumé

Following allogeneic hematopoietic cell transplantation (allo-HCT), the gastrointestinal (GI) tract is frequently affected by acute graft-versus-host disease (aGVHD), the pathophysiology of which is associated with a dysbiotic microbiome. Since microbial composition varies along the length of the GI tract, the authors hypothesized that microbiome features correlate with the pattern of organ involvement after allo-HCT. We evaluated 266 allo-HCT recipients from whom 1303 stool samples were profiled by 16S ribosomal gene sequencing. Patients were classified according to which organs were affected by aGVHD. In the 20 days prior to disease onset, GVHD patients had lower abundances of members of the class Clostridia, lower counts of butyrate producers, and lower ratios of strict-to-facultative (S/F) anaerobic bacteria compared with allograft recipients who were free of GVHD. GI GVHD patients showed significant reduction in microbial diversity preonset. Patients with lower GI aGVHD had lower S/F anaerobe ratios compared with those with isolated upper GI aGVHD. In the 20 days after disease onset, dysbiosis was observed only in GVHD patients with GI involvement, particularly those with lower-tract disease. Importantly, Clostridial and butyrate-producer abundance as well as S/F anaerobe ratio were predictors of longer overall survival; higher abundance of butyrate producers and higher S/F anaerobe ratio were associated with decreased risk of GVHD-related death. These findings suggest that the intestinal microbiome can serve as a biomarker for outcomes of allo-HCT patients with GVHD.

Identifiants

pubmed: 35969834
pii: S0006-4971(22)01036-9
doi: 10.1182/blood.2021015352
pmc: PMC9837450
doi:

Substances chimiques

Butyrates 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2385-2397

Subventions

Organisme : NCI NIH HHS
ID : P01 CA023766
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA228308
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL147584
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA228358
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL143189
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL123340
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG052359
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

© 2022 by The American Society of Hematology.

Références

J Antimicrob Chemother. 2021 Dec 24;77(1):148-154
pubmed: 34561709
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Blood. 2016 Feb 25;127(8):1044-51
pubmed: 26563133
Appl Microbiol. 1969 Mar;17(3):457-61
pubmed: 4388601
Biol Blood Marrow Transplant. 2015 Aug;21(8):1373-83
pubmed: 25977230
Biol Blood Marrow Transplant. 2017 Feb;23(2):340-346
pubmed: 27890428
Biol Blood Marrow Transplant. 2013 Jun;19(6):904-11
pubmed: 23416854
Antimicrob Agents Chemother. 2019 May 24;63(6):
pubmed: 30936104
Blood Adv. 2019 Oct 8;3(19):2866-2869
pubmed: 31585950
ISME J. 2013 Jul;7(7):1256-61
pubmed: 23677008
Cell Host Microbe. 2020 Apr 8;27(4):659-670.e5
pubmed: 32101703
Blood Adv. 2020 May 12;4(9):1824-1832
pubmed: 32353108
Blood. 2018 Jun 28;131(26):2978-2986
pubmed: 29674425
Sci Transl Med. 2018 Sep 26;10(460):
pubmed: 30257956
Mucosal Immunol. 2017 Jan;10(1):18-26
pubmed: 27554295
Nature. 2021 Nov;599(7883):120-124
pubmed: 34646011
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
Nat Biotechnol. 2017 Jan;35(1):81-89
pubmed: 27893703
Antimicrob Agents Chemother. 2006 Oct;50(10):3375-80
pubmed: 17005820
Nutrients. 2019 Jul 08;11(7):
pubmed: 31288415
Elife. 2021 May 04;10:
pubmed: 33944776
Nucleic Acids Res. 2020 Jan 8;48(D1):D445-D453
pubmed: 31586394
Blood. 2000 May 1;95(9):2754-9
pubmed: 10779417
Nature. 2015 Dec 24;528(7583):560-564
pubmed: 26649819
J Nutr. 2009 Sep;139(9):1619-25
pubmed: 19625695
Blood. 2020 Jul 2;136(1):130-136
pubmed: 32430495
Science. 2013 Jun 21;340(6139):1456-9
pubmed: 23661644
Infect Immun. 2019 Jun 20;87(7):
pubmed: 31010813
Blood. 2014 Aug 14;124(7):1174-82
pubmed: 24939656
Biol Blood Marrow Transplant. 2018 Dec;24(12):2418-2424
pubmed: 30055351
Blood. 2011 Dec 15;118(25):6702-8
pubmed: 21979939
J Leukoc Biol. 2017 Dec;102(6):1381-1388
pubmed: 28951425
Biol Blood Marrow Transplant. 2007 Dec;13(12):1469-76
pubmed: 18022577
Adv Cell Gene Ther. 2019 Oct;2(4):
pubmed: 31886456
Science. 2017 Oct 20;358(6361):359-365
pubmed: 29051379
Clin Infect Dis. 2012 Oct;55(7):905-14
pubmed: 22718773
Immunity. 2012 Aug 24;37(2):339-50
pubmed: 22921121
N Engl J Med. 1991 Aug 22;325(8):525-32
pubmed: 1906987
Bone Marrow Transplant. 2017 Aug;52(8):1180-1186
pubmed: 28504665
Cell Host Microbe. 2020 Jul 8;28(1):134-146.e4
pubmed: 32492369
N Engl J Med. 2020 Feb 27;382(9):822-834
pubmed: 32101664
Future Microbiol. 2007 Jun;2(3):285-95
pubmed: 17661703
Gut Microbes. 2020 May 3;11(3):405-420
pubmed: 31203722
J Exp Med. 2002 Aug 5;196(3):389-99
pubmed: 12163567
Cell. 2016 Jun 16;165(7):1708-1720
pubmed: 27264604
Biol Blood Marrow Transplant. 2020 Apr;26(4):778-781
pubmed: 31870930
Sci Transl Med. 2016 May 18;8(339):339ra71
pubmed: 27194729
Gut. 2011 May;60(5):631-7
pubmed: 21209126
J Exp Med. 2012 May 7;209(5):903-11
pubmed: 22547653
Immunity. 2013 Aug 22;39(2):372-85
pubmed: 23973224
Biol Blood Marrow Transplant. 2014 May;20(5):640-5
pubmed: 24492144
Nat Biotechnol. 2013 Sep;31(9):814-21
pubmed: 23975157
Br J Haematol. 2012 Jun;157(6):732-41
pubmed: 22486355
Cell. 2016 Jun 2;165(6):1332-1345
pubmed: 27259147
Exp Hematol. 2003 Oct;31(10):897-902
pubmed: 14550805
Am J Transplant. 2018 Jan;18(1):23-29
pubmed: 28742948
Science. 2019 Nov 29;366(6469):1143-1149
pubmed: 31780560
J Heart Lung Transplant. 2015 Nov;34(11):1385-9
pubmed: 26250966
Cell. 2017 Feb 23;168(5):928-943.e11
pubmed: 28215708
J Antimicrob Chemother. 1984 Dec;14 Suppl D:43-52
pubmed: 6394577
Blood. 2006 Feb 15;107(4):1703-11
pubmed: 16291587
Biol Blood Marrow Transplant. 2015 Apr;21(4):761-7
pubmed: 25585275
Nature. 2013 Dec 19;504(7480):446-50
pubmed: 24226770
Nat Immunol. 2016 May;17(5):505-513
pubmed: 26998764
Science. 2005 Jun 10;308(5728):1635-8
pubmed: 15831718
Clin Infect Dis. 2017 Nov 29;65(12):1984-1991
pubmed: 29020185
Front Nutr. 2022 Jan 13;8:786742
pubmed: 35096932

Auteurs

Marina Burgos da Silva (M)

Department of Immunology, Sloan Kettering Institute, New York, NY.

Doris M Ponce (DM)

Adult Bone Marrow Transplantation Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY.
Department of Medicine, Weill Cornell Medical College, New York, NY.

Anqi Dai (A)

Department of Immunology, Sloan Kettering Institute, New York, NY.

Sean M Devlin (S)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering, New York, NY.

Antonio L C Gomes (ALC)

Department of Immunology, Sloan Kettering Institute, New York, NY.

Gillian Moore (G)

Adult Bone Marrow Transplantation Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY.

John Slingerland (J)

Department of Immunology, Sloan Kettering Institute, New York, NY.

Roni Shouval (R)

Adult Bone Marrow Transplantation Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY.
Department of Medicine, Weill Cornell Medical College, New York, NY.

Gabriel K Armijo (GK)

Department of Immunology, Sloan Kettering Institute, New York, NY.

Susan DeWolf (S)

Leukemia Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY.

Teng Fei (T)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering, New York, NY.

Annelie Clurman (A)

Department of Immunology, Sloan Kettering Institute, New York, NY.

Emily Fontana (E)

Department of Immunology, Sloan Kettering Institute, New York, NY.
Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering, New York, NY.

Luigi A Amoretti (LA)

Department of Immunology, Sloan Kettering Institute, New York, NY.
Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering, New York, NY.

Roberta J Wright (RJ)

Department of Immunology, Sloan Kettering Institute, New York, NY.
Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering, New York, NY.

Hana Andrlova (H)

Department of Immunology, Sloan Kettering Institute, New York, NY.

Oriana Miltiadous (O)

Department of Pediatrics, Memorial Sloan Kettering, New York, NY.

Miguel-Angel Perales (MA)

Adult Bone Marrow Transplantation Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY.
Department of Medicine, Weill Cornell Medical College, New York, NY.

Ying Taur (Y)

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering, New York, NY.

Jonathan U Peled (JU)

Department of Immunology, Sloan Kettering Institute, New York, NY.
Adult Bone Marrow Transplantation Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY.
Department of Medicine, Weill Cornell Medical College, New York, NY.

Marcel R M van den Brink (MRM)

Department of Immunology, Sloan Kettering Institute, New York, NY.
Adult Bone Marrow Transplantation Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY.
Department of Medicine, Weill Cornell Medical College, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH